SecBot SecBot
EFFECT ·Filed Jun 26, 2026

KALA

KALA BIO, Inc.
BEARISH
Impact 7/10
Horizonweeks Processed4mo ago SEC9999999995-26-002122
IPO/offering going effective
Actionable Insight ▼ Bearish

The effectiveness of this shelf, combined with two prior effective S-3s, creates a persistent dilution overhang. Monitor for any takedown announcements or registration statements that specify pricing, a large secondary could pressure the stock significantly given the small market cap.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$2.52
T+0 close · Jun 26, 2026 · via day close
Latest settled
−77.78%
T+60 · $0.5600
Vs SPY
−82.26%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 26 $2.52entry
  2. T+1 · 5mo ago −17.06%α −18.71% · $2.09
  3. T+5 · 4mo ago −33.33%α −35.50% · $1.68
  4. T+20 · 4mo ago −75.78%α −77.04% · $0.6103
  5. T+60 · 8w ago −77.78%α −82.26% · $0.5600
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

KALA BIO's shelf registration (File No. 333-295667) became effective on June 25, 2026, allowing the company to conduct offerings at any time. The underlying S-3 covers the resale of up to 241,435,910 shares of common stock by selling stockholders, primarily from preferred stock conversions and settlement agreements. This creates a substantial potential dilution overhang for a $47M market cap company.

Key Facts

  • Shelf registration effective June 25, 2026, under File No. 333-295667.
  • Covers resale of up to 241,435,910 shares of common stock by selling stockholders.
  • Shares include 12,000,010 Series AA conversion shares, 226,335,900 Series AAA conversion shares, 2,200,000 LifeSci settlement shares, and 900,000 Baker settlement shares.
  • Market cap is approximately $47M, making the potential dilution massive relative to current float.
  • Two prior S-3 filings (Feb 2026 and May 2026) also went effective, compounding the overhang.

Financial Impact

Potential dilution of up to 241.4M shares against a $47M market cap; no specific offering amount or pricing disclosed.

dilutionshare count

Risk Factors

  • Massive potential dilution from up to 241.4M registered shares relative to current float.
  • Multiple effective shelves increase the risk of near-term offerings.
  • Selling stockholders include large holders (Baker Bros., LifeSci) who may seek to exit.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002122
Document: 9999999995-26-002122-index.html9999999995-26-002122
Document: 9999999995-26-002122.txt9999999995-26-002122

Track record

10 reports on KALA

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +68.51% at T+60 after the Jul 22, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 13, 20263d ago NT 10-Q Bearish 7/10 Entry $0.1496 Now $0.1390 +7.09% settles Nov 17
  2. Nov 12, 20264d ago 8-K Bearish 5/10 Entry $0.1388 to $0.1277 Now $0.1390 −0.14% ▲ +8.02% +6.11% vs SPY
  3. Nov 9, 20267d ago 8-K Neutral 4/10 Entry $0.1773 to $0.1710 Now $0.1390 −21.60% ▼ −3.55% −3.19% vs SPY
  4. Oct 19, 202628d ago SC 13G Neutral 3/10 Entry $0.1926 to $0.1897 Now $0.1390 −27.83% ▼ −1.51% −1.84% vs SPY
  5. Sep 24, 20267w ago Press Release Neutral 3/10 Entry $0.5600 to $0.4760 Now $0.1390 −75.18% ▼ −15.00% −15.54% vs SPY
  6. Aug 28, 202611w ago 8-K Bearish 8/10 Entry $0.6901 to $0.6727 Now $0.1390 +79.86% ▲ +2.52% +2.22% vs SPY
  7. Jul 22, 202616w ago 424B5 Bearish 8/10 Entry $0.6103 to $0.6342 Now $0.1390 +77.22% ▼ −3.92% −3.81% vs SPY
  8. Jun 26, 202620w ago EFFECT Bearish 7/10 Viewing Entry $2.52 to $2.09 Now $0.1390 +94.48% ▲ +17.06% +18.71% vs SPY
  9. May 7, 202627w ago S-3 Neutral 2/10 Entry $3.95 to $3.91 Now $0.1390 −96.48% ▼ −1.01% −1.24% vs SPY
  10. Mar 4, 202636w ago Press Release Mixed 6/10 Entry $17.25 to $0.2750 Now $0.1390 −99.19% ▼ −98.41% −97.83% vs SPY
Showing 10 of 10

US Market Status

Market Closed · Opens in 6h 43m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 26, 2026